Syntheses of indole phytoalexin 1-methoxybrassenin B and a linear synthesis of its nucleoside analogs 1-(α-D-ribofuranosyl)brassenin B and 1-(β-D-ribofuranosyl)brassenin B are reported from the corresponding 1-substituted indole-3-carboxaldehydes and carboxylic acids as key intermediates. Examination of the antiproliferative activity of synthesized compounds on human tumor cell lines Jurkat, CEM, CEM-VCR, MCF-7 and HeLa revealed the highest activity for 1-methoxybrassenin B, whereas activity of the nucleoside analogs decreased and appeared to be dependent on lipophilicity.
Introduction
Indole phytoalexins are inducible phytochemicals produced by Brassica plants in response to several forms of stress, including microbial infection. 1 However, their isolation from plants requires complicated procedures and does not afford sufficient quantities for biological studies. With respect to the well known anticarcinogenicity of Brassica vegetables, 1c,2 there is a strong need to investigate the synthetic approaches to 1-methoxyindole phytoalexins and their analogs, including N-glycosylated ones. Indole nucleosides represent a rare type of natural products with interesting biological properties. Among them, nucleoside antibiotic rebeccamycin (1) 3a and its analogs have been identified as attractive cancer chemotherapy agents. 3b Glycosylation of the natural indolocarbazole BE 13793C (2) 4a and its further modification lead to the improvement of its biological properties and yielded a potent anticancer drug J-107,088 (3a), active against human stomach cancer cells MKN-45 implanted to mice. 4b,c From the series of sugar analogues of J-107,088 (3a), the β-D-ribofuranoside J-107,534 (3b) was found to be 6 times more potent than 3a at inhibiting topoisomerase I, an attractive target for cancer chemotherapy. 4d A series of recently described 2,3-substituted-5,6-dichloro-1-(β-D-ribofuranosyl)indole compounds exhibit activity against human cytomegalovirus and herpes simplex virus type I, but this activity was not well separated from cytotoxicity. 5 Within our continuing investigation of the synthesis of cruciferous phytoalexins and their nucleoside analogs, 6 we have focused our effort also towards the synthesis and biological activity of 1-methoxybrassenin B (4a), isolated in 1991 from cabbage (Brassica oleracea var. capitata) inoculated with Pseudomonas cichorii, 7 and its ribofuranosyl analogs 6a and 6b.
Results and Discussion
Synthesis of brassenin B (4b) 8 (the demethoxy analog of 4a) and its 1-(β-D-glucopyranosyl)
analog (5b) 6a have created the starting position for the present investigation of the preparation of 1-methoxybrassenin B and convergent or linear synthesis of its N-ribofuranosides respectively. We started our study by the preparation of 1-(β-D-ribofurosyl)brassenin B (6b) from brassenin B (4b), using a convergent approach. Although, the nucleophilicity of indole nitrogen in general is low, and standard methods used in nucleoside chemistry fail to afford indole nucleosides, several successful ribosylations of indoles are described. 1-(β-D-Ribofuranosyl)indoles were obtained by glycosylation of sodium salts of 2,5,6-trichloroindole and 2-bromo-5,6-dichloroindole 5 or 5-nitroindole 9 with 5-O-tert-butyldimetylsilyl-2,3-O-isopropylidene-α-D-ribofuranosyl chloride. In our case, however, this method failed to afford the desired product, probably because of the low reactivity of starting brassenin B, and only decomposition products were observed. Also unsuccessful was the reaction of brassenin B with 5-O-tert-butyldimethylsilyl-2,3-Oisopropylidene-α-D-ribofuranose via Mitsunobu conditions 10 (PPh 3 , diethyl azodicarboxylate) resulting in acylation of brassenin B with the formation of 1-ethoxycarbonylbrassenin B. Therefore, in the subsequent approaches to the synthesis of the target compounds we focused our attention on linear synthesis, using the indoline-indole method, which offers a possibility to take advantage of the enhanced nucleophilicity of indoline compared to the less nucleophilic indole. In this method a 2,3-dihydroindole (indoline) derivative is reacted in ethanol at room temperature or under reflux in the presence of catalytic amount of acetic acid with a suitable glycosyl donor (frequently a per-O-acetylated saccharide) to form an intermediate glycosyl indoline, which is then oxidized to the glycosylindole derivative. 11 Using this synthetic strategy, the corresponding glycosylated indole-3-carboxaldehydes 12 and 16 were selected as the key intermediates for the linear synthesis of 6a and 6b. At the time we started this study, literature procedures reported 1-acetylindoline as the sole reaction product between per-O-acetylated ribofuranose with indoline. 11 On the other hand, formation of an N-glycosidic bond can be achieved through the reaction of 2,3-Oisopropylidene-D-ribofuranose (8) with indoline (7) as reported. 12 In agreement with literature where it was described that reaction of 2,3-isopropylidene-D-ribofuranose (8) with indoline (7) in anhydrous methanol leads to β-D-ribofuranosylamine 9 as a major product as well as α-Dribofuranosylamine and ribopyranosyl derivative in the ratio (78 : 8 : 14), 12 we isolated 1-(2,3-Oisopropylidene-β-D-ribofuranosyl)indoline (9, Scheme 1) in 64% yield. After the protection of the 5´ hydroxyl with the acetyl group, the obtained indoline 10 was oxidized with DDQ to corresponding indole 11. Oxidation produced a mixture of α-and β-ribofuranosylindoles 11a and 11b in a ratio 68 : 32 (determined by 1 H NMR spectroscopy) obtained in 45 % and 21% yield after chromatography. The anomeric configurations of 11a and 11b were determined by NOEdifference experiments (Figure 1 and 2) . A similar anomerization had been observed at oxidation of 5-fluoro-(5-O-trityl-2,3-di-O-acetyl-β-D-ribofuranosyl)indoline, which yielded the corresponding indole β-and α-ribosides (35% and 8%). 11 Although the mechanism of formation of the α-anomer is not known, it was suggested that DDQ eliminated a hydride ion from the anomeric center to form a carbocation, which can be stabilized by conjugation with the unshared electron pair of the neighboring nitrogen and oxygen atoms. A proton is then eliminated and a hydrogen transferred from the pyrrole ring to the anomeric carbon of the planar carbonium ion from either face to produce a mixture of β-and α-anomers. 11 The unexpected formation of α-ribofuranosylindole 11a opened the way to synthesis of 6a. Indole 11a was subjected to a Vilsmeier reaction and aldehyde 12 was obtained in 86% yield. Because of the low yield of β-anomeric indole 11b, we have been searching for another way to obtain suitably protected 1-(β-D-ribofuranosyl)indole-3-carboxaldehyde. Consequently, we decided to verify the information that the reaction of peracetylated ribofuranose 13 with indoline (7) produces only 1-acetylindoline. 11 It was found that condensation of protected ribose 13 with 3 equivalents of indoline under reflux during 6 hours afforded the desired 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)indoline (14) in 63% yield after column chromatography in addition to the 1-acetylindoline (Scheme 2). We presented this result in 2003 on the 10 th Blue Danube Symposium on Heterocyclic Chemistry in Vienna. 6e In the same year, an analogous preparation of 14 in 55% yield after preparative TLC was published using 2 equivalents of indoline under reflux for 27 hours. 13 Oxidation of 14 with DDQ afforded 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)indole (15) of very high purity in 98% yield without chromatography. 6a In this way, 1-methoxyindole-3-carboxylic acid 18 was prepared in 50% yield. However, oxidation with NaClO 2 in a mixture of t-BuOH and 2-methylbut-2-ene over 39 hours returned an excellent 95% yield in accordance with the literature. 16 Application of a NaClO 2 oxidation to α-and β-ribofuranosylindol-3-carbaldehydes 12 and 16 afforded acids 19 and 20 in 91% and 81% yield with shorter reaction times of 8.5 and 5.5 hours respectively. Owing to the low solubility of aldehydes 12 and 16 in t-BuOH and 2-methylbut-2-ene, dioxane had to be added to achieve complete dissolution of starting compounds. In the next step, treatment of acids 18-20 with PCl 3 afforded the unstable acid chlorides 21-23, which were used in subsequent reactions as crude products. In the synthesis of 1-methoxybrassenin B (4a), we examined an approach via the acyl isothiocyanate used in the preparation of its demethoxyanalog 4b. 8 Transformation of acid chloride 21 to acyl isothiocyanate 24 (Scheme 3) proceeded smoothly and the product could be isolated by column chromatography and crystallization or preferably used in the next step as a crude product. Reaction of isothiocyanate 24 with NaSH and methyl iodide afforded dithiocarbamate 25 (23% yield from acid 18) and thioester 26 (25% yield from acid 18) as a side product. Methylation of 25 afforded 1-methoxybrassenin B (4a, 81%). The efficiency of this method was low, because the important intermediate 25 was formed only in 23% yield. Finally, the target phytoalexin 4a was advantageously prepared in 47% yield by the acylation of dimethyl carbonimidodithioate hydroiodide 17 with acid chloride 21 in pyridine. This reaction was previously used in the case of pyridine-4-carbonyl chloride 18 and a protected derivative of glucopyranosylindol-3-carbonyl chloride 6a . Application of this method to ribofuranosyl acid chlorides 22 and 23 afforded the α-and β-anomers of protected ribofuranosyl derivatives of 27 and 29 in 46 and 39% yield from the acids 19 and 20, respectively. The target nucleosides derived from 1-methoxybrassenin B were obtained by final deprotection. The removal of the isopropylidene group of 27 with trifluoroacetic acid and subsequent treatment of 5'-O-acetyl derivative 28 with sodium methoxide afforded 1-(α-D-ribofuranosyl)brassenin B (6a). The deprotection of peracetylated compound 29 with catalytic amount of sodium methoxide in methanol smoothly afforded target compound 6b. The structures of all nucleoside analogs were confirmed by spectral methods. In their 1 H and 13 C NMR spectra, the signals were assigned on the basis of 2D COSY and hetero-correlated HSQC spectra. The structures of α-and β-ribofuranosylindole 11a and 11b were determined by NOE experiments depicted on Figure 1 It was our final goal to obtain information about antiproliferative activities of the synthesized compounds and compare them with phytoalexin aglycons as well as previously prepared 1-(β-Dglucopyranosyl) derivatives 5a and 5b. The antiproliferative activities were examined towards Jurkat cells (acute T-lymphoblastic leukemia), CEM (acute T-lymphoblastic leukemia), CEM-VCR (acute T-lymphoblastic leukemia, VCR-resistant), MCF-7 (mammary gland adenocarcinoma, estrogen receptor expressed), HeLa (cervix carcinoma) by an MTT (thiazolyl blue) test 19 in a culture medium containing the tested chemicals at a concentration of 10 -4 mol×L -1 after 72 h incubation. The determined activity of compounds is given in Table 1 as the percent of living cells compared to solvent control (100%). The highest activity was found with indole phytoalexin 1-methoxybrassenin B (4a), whereas its demethoxy analog 4b was less active in all tested cell lines. Replacement of the methoxy group by a protected glycosyl moiety resulted in a small decrease of activity, with ribofuranosyl derivatives 27 and 29 being generally more active compared to glucopyranosyl derivative 5a. Nucleoside analogs 5b, 6a and 6b obtained after removal of the protecting groups almost completely lost antiproliferative activity, probably because of decreased lipophilicity. Compounds with a marked activity at 10 -4 mol×L -1 were examined at the concentrations 10 -5 -10 -9 mol×L -1 . A weak activity was found only in Jurkat cells, where compounds 4a, 4b, 5a and 29 at a concentration of 10 -6 mol×L -1 inhibited proliferation to 80-90%. Microanalyses were performed with a Perkin-Elmer, Model 2400 analyzer. The EI mass spectra were recorded on a Finigan SSQ 700 spectrometer at ionization energy of 70 eV, whereas MALDI-TOF mass spectra were measured on a MALDI IV (Shimadzu, Kratos Analytical). The samples were ionized with a N 2 -laser (λ = 337 nm). The progress of chemical reactions was monitored by thin layer chromatography, using Macherey-Nagel plates Alugram ® Sil G/UV254. Preparative column chromatography was performed on Kieselgel Merck Typ 9385 (40-63 µm).
1-(2,3-O-Isopropylidene-β-D-ribofuranosyl)indoline (9)
To a solution of 2,3-O-isopropylidene-D-ribofuranose 20 (8, 6 .243 g, 32.82 mmol) in anhydrous methanol (10 mL) was added indoline (7, 3.68 mL, 3.911g, 32.82 mmol) and reaction mixture was stirred under reflux for 5 h, then concentrated in vacuum and the obtained residue chromatographed on silica gel (150 g, hexane/acetone 3/1) to give 9 (6.1 g, 64%), as light yellow oil. Spectral data were identical with the described compound. 
Oxidation of 10 with DDQ
To a solution of 10 (3.622 g, 10.86 mmol) in anhydrous toluene (57 ml) was added dropwise within 15 min a solution of DDQ (2.7 g, 11.95 mmol) in anhydrous toluene (57 ml). Reaction mixture was stirred for 10 min at room temperature and then poured into 4% aqueous solution of K 2 CO 3 (100 mL). The product was extracted with CHCl 3 (100 and 50 mL). The combined extracts were washed with water (100 and 50 mL), dried over Na 2 SO 4 and concentrated under reduced pressure. Chromatography on silica gel (75 g, cyclohexane/ethyl acetate 20/1) of the obtained residue afforded compounds 11a (1.627 g, 45%) and 11b (0.75 g, 21%) as colorless oils. 
1-(2,3-O-Isopropylidene-5-O-acetyl-α-D-ribofuranosyl)indole-3-carboxldehyde (12)
To a solution of indole 11a (2.57 g, 7.76 mmol) in dry DMF (8.2 mL) cooled to 0 °C was added dropwise a mixture of POCl 3 (2.06 mL, 3.45 g, 22.50 mmol) in dry DMF (6.5 mL) prepared at 0 °C. Reaction mixture was stirred for 20 min at room temperature, until the starting material was consumed (TLC monitoring, eluent cyclohexane/ethyl acetate 3/1). Reaction mixture was poured into crushed ice (60 mL), neutralized with 4% aqueous solution of K 2 CO 3 (330 ml), extracted with diethyl ether (3×60 mL) and dried over Na 2 SO 4 . After removal of the solvent, the residue was crystallized from propan-2-ol to give 12 ( 
1-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)indole (15)
To a solution of indoline 14 (1.48 g, 3.93 mmol) in anhydrous toluene (20 mL) was added dropwise a solution of DDQ (0.98 g, 4.32 mmol) in dry toluene (20 mL) within 10 min. Reaction mixture was stirred at room temperature for 1 h and then poured into 4% aqueous solution of K 2 CO 3 (40 mL). The product was extracted with CHCl 3 (2×30 mL), combined extracts washed with water (2×75 mL), dried over Na 2 SO 4 
1-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)indole-3-carboxaldehyde (16)
To a solution of indole 15 (1.45 g, 3.86 mmol) in dry DMF (4 mL) cooled to 0 °C was added dropwise a mixture of POCl 3 (1.7 g, 1.02 mL, 11.1 mmol) in dry DMF (3.4 mL) prepared at 0 °C. Reaction mixture was stirred for 15 min at 0 °C and 1 h at room temperature, then poured into crushed ice (100 ml), neutralized with 4% aqueous solution of K 2 CO 3 (160 mL), extracted with ethyl acetate (2×50 mL) and dried over Na 2 SO 4 . After removal of the solvent, the residue was crystallized from diethyl ether to give 16 (0.96 g, 61%) as colorless crystals. 
1-(2,3-O-Isopropylidene-5-O-acetyl-α-D-ribofuranosyl)indole-3-carboxylic acid (19)
A solution of 80% NaClO 2 (3.46 g, 30.61 mmol) and NaH 2 PO 4 .2H 2 O (3.58 g, 22.95 mmol) in water (15 mL) was added at 0 °C to a suspension of aldehyde 12 (0.55 g, 1.53 mmol) in tertbutyl alcohol (15 mL) and 2-methylbut-2-ene (15 mL). Dioxane (5 mL) was added to dissolve starting aldehyde 12 and the mixture was stirred at room temperature for 8.5 h (TLC, monitoring, eluent cyclohexane/acetone 2/1). After dilution with water (45 mL), the product was extracted with chloroform (2×30 ml), extract washed with brine (60 mL) and water (40 mL), dried over Na 2 SO 4 , solvent evaporated under reduced pressure and the residue submitted to chromatography on silica gel ( 
1-Methoxyindole-3-ylcarbonyl Isothiocyanate (24)
To a solution of crude chloride 21 freshly prepared from 0.5 mmol of acid 18 was added a solution of KSCN (0.048 g, 0.5 mmol) in dry acetone (1 mL). The reaction mixture was stirred at room temperature for 1 h, solvent evaporated and the obtained crude isothiocyanate was immediately used in next reaction or isolated by flash chromatography on silica gel (5g, cyclohexane/acetone 3/1) to give 24 (0.042 g, 36%) as unstable colorless crystals, mp 53-60 °C (acetone/hexane). IR (CHCl 3 ) λ (cm -1 ) 1966 (NCS), 1680 (C=O).
Reaction of 24 with NaSH and CH 3 I
To a solution of crude isothiocyanate 24, obtained from 0.5 mmol of acid 18, in dry THF (2 mL) and dry DMF (0.5 mL) was added methyl iodide (0.16 g, 0.07 mL, 
Synthesis of 1-methoxybrassenin B (4a) by methylation of 25
To the solution of 25 (0.033 g, 0.12 mmol) in dry acetone (1 mL) was added methyl iodide (0.022 mL, 0.5 g, 0.36 mmol) and powdered K 2 CO 3 (0.017 g, 0.12 mmol) and mixture was stirred at room temperature for 1 h. Reaction mixture was then poured into cold water (20 mL), extracted with ethyl acetate (10 and 2×5 mL) and dried over Na 2 SO 4 . After evaporation of solvent the residue was crystallized from ethyl acetate/hexane to give 4a (0.028 g, 81%) as colorless crystals, mp 71-73 °C; lit. 7 73-74 °C, spectral data are identical with natural 1-methoxybrassenin B.
7
General procedure for preparation of 1-methoxybrassenin B (4a) and its analogs 27, 29
To a stirred solution of crude acid chloride 21, 22 or 23 freshly prepared from 0.5 mmol of acid 18, or 1 mmol of 19 or 20, was added a solution of dimethyl carbonimidothioate hydroiodide (0.5 mmol for 4a and 1 mmol for 27 or 29) in pyridine (2 mL or 8 mL) and reaction mixture was stirred at room temperature for 30 min (4a), 1 h (27) and 1.5 h (29). After pouring into water (50 mL or 150 mL), the product was extracted with diethyl ether (3×20 mL or 3×75 mL), the extract washed with saturated solution NaHCO 3 (3×60 mL or 3×70 mL), dried over Na 2 SO 4 , solvent evaporated and the residue chromatographed on silica gel.
1-(β-D-Ribofuranosyl)brassenin B (6b)
To a stirred solution of triacetyl derivative 29 (0.1 g, 0.20 mmol) in dry methanol (2 mL) was added 0. Cell culture CEM (human T-cell acute lymphoblastic leukemia cells) and drug-resistant sublines CEM/VCR (vincristine-selected) as well as Jurkat cells (human acute T-lymphoblastic leukemia cells), MCF-7 cells (breast cancer) and HeLa cells (cervix cancer) were kindly provided by Dr. M. Hajdúch (Olomouc, Czech Republic). Cells were maintained in RPMI 1640 medium (CEM, CEM-VCR, Jurkat and HeLa cells) or Dulbeco´s medium (MCF-7 cells) with Glutamax-I supplemented with 10% fetal calf serum, penicillin (100 IU×mL -1 ) and streptomycin (100 µg×mL -1 ) (all from Invitrogen, UK), in the atmosphere 5% CO 2 in humidified air at 37 °C. Cell viability, estimated by trypan blue exclusion, was greater than 95% before each experiment.
Assessment of antiproliferative activity by MTT assay
The antiproliferative activity of the synthesized compounds was examined by MTT (thiazolyl blue) test 19 using the selected human cancer cell lines. Briefly, 1×10 4 cells were plated per well in 96-well polystyrene microplates (Sarstedt, Germany) in the culture medium containing the tested chemicals at final concentrations 10 -4 -10 -9 mol×L -1 . After 72 h incubation, 10 µL of MTT (5 mg×mL -1 ) were added in each well. After additional 4 h, during which insoluble formazan was produced, 100 µl of 10% sodium dodecylsulphate were added in each well and another 12 h were allowed the formazan to be dissolved. The absorbance was measured at 540 nm using the automated MRX microplate reader (Dynatech laboratories UK). Absorbance of control wells was taken as 100%, and the results were expressed as a percent of control.
